An Innovative Health Services & Translational Eye Research Program For Australians Living With Eye Diseases
Funder
National Health and Medical Research Council
Funding Amount
$256,801.00
Summary
My research is focused on the prevention; treatment; and improvement in the quality of life of people with eye diseases, in particular those with diabetic retinopathy (DR), the most common complication of diabetes and a blinding eye condition. My work focuses on three main areas: (a) determining the effectiveness of interventions to prevent and treat DR; (b) evaluating new therapies and biomarkers for DR; (c) evaluating patient-centred, clinical, and economic effectiveness of new treatments for ....My research is focused on the prevention; treatment; and improvement in the quality of life of people with eye diseases, in particular those with diabetic retinopathy (DR), the most common complication of diabetes and a blinding eye condition. My work focuses on three main areas: (a) determining the effectiveness of interventions to prevent and treat DR; (b) evaluating new therapies and biomarkers for DR; (c) evaluating patient-centred, clinical, and economic effectiveness of new treatments for other eye diseases.Read moreRead less
I am a physiologist and my diabetes research involves a preclinical approach to address the issue of diabetes and its major renal and cardiovascular complications
Prof Cooper’s diabetes research encompasses basic mechanisms through to translational research and major clinical trials in order to address the issue of diabetes and in particular the prevention and management of its major renal and cardiovascular complications.
I am a clinician scientist and fully trained nephrologist. My research involves preclinical and clinical translational approaches to identify new targets and to develop new treatments to prevent, reverse and retard diabetes related micro-and macrovascular
I am a clinician scientist and nephrologist. My research involves preclinical and clinical translational approaches to identify new targets and develop novel treatments to prevent, reverse and retard the development and progression of diabetic complications.